entertainment -WSS

entertainment

author：hotspot 2025-09-28 01:36:02 - browse：116

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Immunocompromised patients offer clues on chronic Covid

WSS

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Medicare bonuses could stop drug shortages under Senate plan

Flu vaccine reformulation won't be easy, manufacturers warn

Prior authorization reform is both possible and imperative

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

A pediatrician calls for Congress to pass the child tax credit deal

knowledge

entertainment

knowledge

Moonlake's readout produced a cash windfall. Risks remain

Congress considering partial increase for doctor pay in Medicare

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

High breast density mammograms need follow

Apple is now the first public company to be valued at $3 trillion

ACIP vaccine advisory panel sees its vacancies filled

Continuity nursing helped my family in our darkest PICU moments

To bolster infectious disease surveillance, genomics powerhouses team up

Malaria cases in Florida and Texas: Here’s what you need to know

FDA sets aggressive timeline for overhauling inspection procedures

hotspot

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Tome Biosciences co

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

STAT Boddities: What happens to the brain when we get scared?

Medicare bonuses could stop drug shortages under Senate plan

Dog Aging Project founders on what lies ahead after losing funding

hotspot

knowledge

Wikipedia

Wikipedia